The unsurprising story of MDR-TB resistance in India

Tuberculosis

Volumn 92, Issue 4, 2012, Pages 301-306

  Babu, Giridhara R ^a,b   Laxminarayan, Ramanan ^a  

^a PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DOTS (directly observed treatment strategy) drugs; Multidrug resistant tuberculosis; Resistance in India; Revised National Tuberculosis Control Program (RNTCP); Totally drug resistant TB

Indexed keywords

TUBERCULOSTATIC AGENT;

ATTITUDE TO HEALTH; BACTERIAL VIRULENCE; HEALTH CARE SYSTEM; HUMAN; INDIA; MEDICAL PRACTICE; MULTIDRUG RESISTANT TUBERCULOSIS; POVERTY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SHORT COURSE THERAPY; TREATMENT REFUSAL; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; DELIVERY OF HEALTH CARE; DIRECTLY OBSERVED THERAPY; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; INDIA; MEDICATION ADHERENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84862016373     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.02.009     Document Type: Review

References (37)

1. World Health Organization Emergence of XDR-TB Sep. 2006 Downloaded from: http://www.who.int/mediacentre/news/notes/2006/np23/en/index.html [accessed 20.01.12]
2. Giridhara R. Babu "Opportunities for improving public health system in India" analysis of current state of affairs and pointers for future Ann Trop Med Public Health 4 2011 69 70
3. Global tuberculosis control: WHO report 2011. Downloaded from web: http://whqlibdoc.who.int/publications/2011/9789241564380-eng.pdf [p. 11, accessed 26.01.12].
4. World Health Organization, Country office for India. Tuberculosis. Downloaded from web: http://whoindia.org/en/Section3/Section123.htm [accessed 26.01.12].
5. Zarir F. Udwadia, Rohit A. Amale, Kanchan K. Ajbani, and Camilla Rodrigues Totally drug-resistant tuberculosis in India Clin Infect Dis 54 4 2012 579 581 10.1093/cid/cir889 first published online December 21, 2011
6. Samuel Loewenberg India reports cases of totally drug-resistant tuberculosis The Lancet 379 9812 21 January 2012 205 10.1016/S0140-6736(12) 60085-3
7. A. Singh XDR-TB: Indian perspective Eur Respir J 30 2007 178 179 10.1183/09031936.00027907
8. World Health Organization Forty-fourth world health assembly. Resolution WHA 44.8 1991 World Health Organization Geneva Available: http://policy.who.int/ cgi-bin/om-isapi.dll?hitsperheading=on&infobase=wha&record= 2496&softpage=Document42 [accessed 20.09.10]
9. A. Attaran An immeasurable crisis? A criticism of the millennium development goals and why they cannot be measured PLoS Med 2 10 2005 e318 10.1371/journal.pmed.0020318
10. Kenneth G. Rothman, S. Greenland, and T.L. Lash K.J. Rothman, S. Greenland, T.L. Lash, Modern epidemiology 3rd ed. 2008 Lippincott Williams & Wilkins Philadelphia [chapters 1-21]
11. L.S. Chauhan, and S.P. Agarwal Revised national tuberculosis control programme Agarwal Chauhan Tuberculosis control in India 2005 Directorate General of Health Services/Ministry of Health and Family Welfare, Elsevier Ltd 23 34 Downloaded from web: http://www.tbcindia.org/Documents.asp# [chapter 3, accessed 01.03.12]
12. V. Begum, M.J. Van Der Werf, M. Becx-Bleumink, and M.W. Borgdorff Viewpoint: do we have enough data to estimate the current burden of tuberculosis? The example of Bangladesh Trop Med Int Health 12 2007 317 322 10.1111/j.1365-3156.2006.01790.x
13. M.J. Van Der Werf, and M.W. Borgdorff How to measure the prevalence of tuberculosis in a population Trop Med Int Health 12 2007 475 484 10.1111/j.1365-3156.2006.01799.x
14. S.S. Nair Ethical aspects of the Revised National Tuberculosis Control Programme Indian J Med Ethics VIII 2 Apr-Jun 2011
15. Giridhara R. Babu Comment on 'From risk factors to explanation in public health' J Public Health 30 4 2008 515 10.1093/pubmed/fdn080
16. Giridhara R. Babu Do you see an elephant or just its trunk? The need of learning modern epidemiologic methods: an introduction Internet J Epidemiol 10 Issue 2 2012
17. N.K. Ganguly, N.K. Arora, S.J. Chandy, M.N. Fairoze, J.S. Gill, U. Gupta, S. Hossain, S. Joglekar, P.C. Joshi, M. Kakkar, A. Kotwani, A. Rattan, H. Sudarshan, K. Thomas, C. Wattal, A. Easton, and R. Laxminarayan Rationalizing antibiotic use to limit antibiotic resistance in India Indian J Med Res 134 2011 281 294
18. L.V. Sacks, S. Pendle, D. Orlovic, L. Blumberg, and C. Constantinou A comparison of outbreak- and nonoutbreak-related multidrug-resistant tuberculosis among human immunodeficiency virus-infected patients in a South African hospital Clin Infect Dis 29 1999 96 101
19. William A. Wells, Colin Fan Ge, Nitin Patel, Teresa Oh, Elizabeth Gardiner, and Michael E. Kimerling Size and usage patterns of private TB drug markets in the high burden countries PLoS ONE 6 5 May 2011 e18964
20. Healthcare spending to go up by 2.5% in 12th Five Year Plan: Montek Singh Ahluwalia The Economic Times 2011 Downloaded from web: http://articles. economictimes.indiatimes.com/2011-12-01/news/30463288-1-healthcare-sector- private-sector-ppp [accessed 20.01.12]
21. S. Borrell, and S. Gagneux Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis Int J Tuberc Lung Dis 13 2009 1456 1466
22. S.R. Atre, D.T. D'Souza, T.S. Vira, A. Chatterjee, and N.F. Mistry Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India Indian J Public Health 55 2011 14 21
23. Grand challenges in global health January 25, 2012 Bill and Melinda Gates Foundation Downloaded from web: http://www.gatesfoundation.org/global-health/ Pages/grand-challenges-explorations.aspx
24. World Health Organization, Regional Office for South-East Asia. Involving private medical practitioners in TB and STI control: experiences in public-private partnerships. www.searo.who.int/en/Section10/Section18/ Section356/Section413-1889.htm [accessed 01.03.07; updated: April 2006].
25. Z.F. Udwadia, L.M. Pinto, and M.W. Uplekar Tuberculosis control by private practitioners in Mumbai, India: has anything changed in two decades? PLoS ONE 5 2010 e1203
26. J.A. Singh, R. Upshur, and N. Padayatchi XDR-TB in South Africa: no time for denial or complacency PLoS Med 4 2007 e50 10.1371/journal.pmed.0040050
27. S. McGregor South Africa urged to isolate "killer" TB patients Mail Guardian 2007 January 22 Available: http://www.alertnet.org/thenews/ newsdesk/L23916489.htm [accessed 16.03.07]
28. Goemaere Eric, Ford Nathan, Berman Daniel, McDermid Cheryl, Cohen Rachel. XDR-TB in South Africa: detention is not the priority. PLoS Med 4(4):e162.
29. World Health Organization Factsheet on tuberculosis, Media center Nov 2010 Downloaded from web: http://www.who.int/mediacentre/factsheets/fs104/en/ index.html [accessed 20.01.12]
30. A.R. Escombe, C.C. Oeser, R.H. Gilman, M. Navincopa, and E. Ticona Natural ventilation for the prevention of airborne contagion PLoS Med 4 2007 e68 10.1371/journal.pmed.0040068
31. Médecins Sans Frontières No time to wait: overcoming the gaps in TB drug research and development 2007 Summary of a symposium organized by Médecins Sans Frontières, New York, January 11-12, 2007. Available: http://www.accessmed-msf.org/prod/publications.asp?scntid= 19320071730523&contenttype=PARA& [accessed 26.03.07]
32. Tuberculosis Control Program. Ministry of Health and Family Welfare services, Government of India. Downloaded from website: http://mohfw-epw.gov.in/ index.php?option=com-content&view=article&id=68%3Arntcp-launches-cat-iv- dots-plus-treatment-for-multi-drug-resistant-tb&catid=46%3Afacts-a- figures&Itemid=57 [accessed 14.02.12].
33. Global tuberculosis control: WHO report 2011. Downloaded from web: http://whqlibdoc.who.int/publications/2011/9789241564380-eng.pdf [accessed 26.01.12, p. 25-6].
34. Anonymous. Downloaded from the web: http://www.dnserp.com/Tuberculosis/ MDRIndia.htm [accessed 14.02.12].
35. G.B. Migliori, R. Loddenkemper, F. Blasi, and M.C. Raviglione 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J 29 2007 423 427 10.1183/09031936.00001307
36. WHO/IUA TLD. Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world. Report No. 2. WHO/CDS/TB/2000.278.
37. Working group of The University of Toronto Joint Centre for Bioethics Ethics and SARS: learning lessons from the Toronto experience 2003 Available: http:www.yorku.ca/igreene/sars.html [accessed 18.09.06]